Clinical and Radiological Outcomes: Two-level Cervical ProDisc-C Vivo Versus Hybrid Construct.

Launched by PEKING UNIVERSITY PEOPLE'S HOSPITAL · Dec 4, 2017

Keywords

ClinConnect Summary

This clinical trial is looking at two different surgical options for patients with cervical disc disease, which is a condition affecting the discs in the neck that can cause pain and other symptoms. Specifically, the trial will compare a device called ProDisc-C, used in surgery on two levels of the cervical spine, to a hybrid surgical approach that combines different techniques. The goal is to see which method provides better results in terms of recovery and improvement in symptoms.

To be eligible for this trial, participants must have been diagnosed with degenerative disc disease at two levels in the neck (between the third and seventh cervical vertebrae) and have symptoms that haven't improved with non-surgical treatments for at least six weeks. Patients should also be experiencing worsening symptoms that require surgery. Unfortunately, if someone has already had surgery on their cervical spine, they won't be able to participate. While the trial is not yet recruiting participants, it aims to gather valuable information to help improve treatment options for those suffering from this condition.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • A diagnosis of degenerative disc disease with radiculopathy or myeloradiculopathy at 2 contiguous levels from C-3 to C-7.
• • The symptom is unresponsive to nonoperative treatment for at least 6 weeks.
• • The patient demonstrates progressive symptoms calling for immediate surgery.
• Exclusion Criteria:
• • Any prior cervical spine surgery.